LOXL2-mediated H3K4 oxidation reduces chromatin accessibility in triple-negative breast cancer cells by Cebrià-Costa, J. P., Pascual-Reguant, L., Gonzalez-Perez, A., Serra-Bardenys, G., Querol, J., Cosín, M., Verde, G., Cigliano, R. A., Sanseverino, W., Segura-Bayona, S., Iturbide, A., Andreu, D., Nuciforo, P., Bernado-Morales, C., Rodilla, V., Arribas, J., Yelamos, J., de Herreros, A. Garcia, Stracker, T. H., Peiró, S.

Get full text

Pancreatic cancer heterogeneity and response to Mek inhibition by Pedersen, K, Bilal, F, Bernadó Morales, C, Salcedo, M T, Macarulla, T, Massó-Vallés, D, Mohan, V, Vivancos, A, Carreras, M-J, Serres, X, Abu-Suboh, M, Balsells, J, Allende, E, Sagi, I, Soucek, L, Tabernero, J, Arribas, J

Get full text

Coamplification of miR-4728 protects HER2-amplified breast cancers from targeted therapy by Floros, Konstantinos V., Lochmann, Timothy L., Hu, Bin, Monterrubio, Carles, Hughes, Mark T., Wells, Jason D., Morales, Cristina Bernadó, Ghotra, Maninderjit S., Costa, Carlotta, Souers, Andrew J., Boikos, Sosipatros A., Leverson, Joel D., Tan, Ming, Serra, Violeta, Koblinski, Jennifer E., Arribas, Joaquin, Prat, Aleix, Paré, Laia, Miller, Todd W., Dozmorov, Mikhail G., Harada, Hisashi, Windle, Brad E., Scaltriti, Maurizio, Faber, Anthony C.

Get full text